CXCL12 and neoplasm: In this study, we surprisingly found a dramatic reduction in tumor sizes in mice treated with CXCL12/CSF1 neutralizing antibodies together with anti‐PD1 antibody, and CD8+ T cell infiltration was markedly increased.